Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.

@article{Gomez2015TimeTT,
  title={Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival.},
  author={Daniel Richard Gomez and Kai-Ping Liao and Stephen G Swisher and George R. Blumenschein and Jeremy J. Erasmus and Thomas A. Buchholz and Sharon Hermes Giordano and Benjamin D. Smith},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2015},
  volume={115 2},
  pages={257-63}
}
PURPOSE Prompt staging and treatment are crucial for non-small cell lung cancer (NSCLC). We determined if predictors of treatment delay after diagnosis were associated with prognosis. MATERIALS AND METHODS Medicare claims from 28,732 patients diagnosed with NSCLC in 2004-2007 were used to establish the diagnosis-to-treatment interval (ideally ⩽35days) and identify staging studies during that interval. Factors associated with delay were identified with multivariate logistic regression, and… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
11 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Similar Papers

Loading similar papers…